<SEC-DOCUMENT>0001493152-22-009272.txt : 20220406
<SEC-HEADER>0001493152-22-009272.hdr.sgml : 20220406
<ACCEPTANCE-DATETIME>20220406160537
ACCESSION NUMBER:		0001493152-22-009272
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220401
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220406
DATE AS OF CHANGE:		20220406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		22810619

	BUSINESS ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:MBOT="http://microbotmedical.com/20220401">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_MBOT_microbotmedical.com_20220401 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20220401_20220401 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000883975 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityCentralIndexKey">0000883975</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mbot-20220401.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-04-01to2022-04-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_903_edei--DocumentType_c20220401__20220401_zLDuI4WIuOJb"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_902_edei--DocumentPeriodEndDate_c20220401__20220401_zmfCmzSvyk5i"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 1, 2022</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90B_edei--EntityRegistrantName_c20220401__20220401_zG7ouLh5wR9g"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityRegistrantName">MICROBOT
MEDICAL INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20220401__20220401_zs6oGoShorv3"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20220401__20220401_zpia7WcVBd56"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityFileNumber">000-19871</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20220401__20220401_ziXzrxsG8Soi"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityTaxIdentificationNumber">94-3078125</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission
    </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_904_edei--EntityAddressAddressLine1_c20220401__20220401_zDdRpGR9UPGe"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressAddressLine1">25
    Recreation Park Drive</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20220401__20220401_zfqoNIgDwFsb"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressAddressLine2">Unit 108</ix:nonNumeric></span></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20220401__20220401_zJnaL4h7Cvxd"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressCityOrTown">Hingham</ix:nonNumeric></span>,
    <span id="xdx_905_edei--EntityAddressStateOrProvince_c20220401__20220401_zsltSLAMtAHd"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20220401__20220401_zmZ5r4TFwHRj"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:EntityAddressPostalZipCode">02043</ix:nonNumeric></span></b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
    of Principal Executive Offices) (Zip Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code: <span id="xdx_902_edei--CityAreaCode_c20220401__20220401_zHYNT8AUDsf1"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:CityAreaCode">(781)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20220401__20220401_zoGkslIfe6t3"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:LocalPhoneNumber">875-3605</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
Name or Former Address, if Changed Since Last Report)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20220401__20220401_zji6JuZcpGL5"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--SolicitingMaterial_c20220401__20220401_zsksRGBO5PJ1"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20220401__20220401_zpxMxvpgUdm8"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20220401__20220401_zScBJuAgz89d"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20220401__20220401_z3VRLNnY1Njk"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20220401__20220401_znrngeUCT1q2"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" name="dei:TradingSymbol">MBOT</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--SecurityExchangeName_c20220401__20220401_zUIuStiXgLf6"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
Growth Company <span id="xdx_903_edei--EntityEmergingGrowthCompany_c20220401__20220401_zgSHbvmPiDi5"><ix:nonNumeric contextRef="From2022-04-01to2022-04-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    5.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
    of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 1, 2022, David Ben Naim, the Chief Financial Officer of Microbot Medical Inc. (the &#8220;Company&#8221;), resigned from his
position with the Company, effective immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 1, 2022, the Company appointed Rachel Vaknin, age 43, as its Chief Financial Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Vaknin has been the Vice President-Finance, of the Company since January 2022. Prior to that, she was the Chief Financial Officer of
Imagry, an Israeli-American autonomous technologies software provider, from September 2017 through December 2021. From April 2004 through
December 2016, Ms. Vaknin was the FP&amp;A Department Manager at Mellanox Technologies Ltd., an Israeli-American multinational supplier
of computer networking products acquired by Nvidia in 2020, where she was responsible, among other things, for budget planning, budget
control, building and maintaining business intelligence key performance indicators, leading teams with respect to preparing quarterly
financial statements, obtaining and managing grant monies, and Sarbanes-Oxley controls.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an employment agreement (the &#8220;Agreement&#8221;), dated November 22, 2021, with Ms. Vaknin, to serve as the
Company&#8217;s Vice President of Finance, on an indefinite basis subject to the termination provisions described in the Agreement. There
were no changes or revisions to the Agreement as a result of Ms. Vaknin&#8217;s elevation and promotion to Chief Financial Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Agreement, Ms. Vaknin receives a base salary of NIS32,000 per month plus &#8220;global compensation&#8221; of NIS8,000
per month for overtime. Ms. Vaknin is also entitled to receive an annual cash bonus of up to 20% of annual salary, contingent on meeting
targets as shall be determined from time to time by the Company at its sole discretion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Vaknin shall be further entitled to reimbursement of commuting expenses in the amount of NIS1,000 per month or, alternatively, a leased
motor vehicle. In the event Ms. Vaknin elects to receive the motor vehicle, her base salary shall be adjusted to NIS29,600 per month
and her global compensation shall be reduced to NIS7,400 per month.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Vaknin was initially granted options in January 2022 to purchase 20,000 shares of common stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Agreement, the Company pays to an insurance company or a pension fund, for Ms. Vaknin, an amount equal to 8.33% of the salary,
which shall be allocated to a fund for severance pay, and an additional amount equal to 6.5% of the salary, which shall be allocated
to a provident fund or pension plan. The Company also pays an additional sum for disability insurance to insure Ms. Vaknin for up to
75% of the salary, and 7.5% of each monthly payment to be allocated to a &#8220;study fund.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Either
the Company or Ms. Vaknin may terminate the Agreement without cause (as determined pursuant to the Agreement) by providing the other
party with sixty days prior written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Agreement for cause at any time by written notice without any advance notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Agreement contains customary non-competition and non-solicit provisions pursuant to which Ms. Vaknin agrees not to compete with, or solicit
third parties with respect to business activities relating to, the Company. Ms. Vaknin also agreed to customary terms regarding confidentiality
and ownership of intellectual property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">The foregoing is a
brief description of the Agreement and the material terms of the Agreement and is qualified in its entirety by reference to the full
text of the Agreement, which is filed herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
    FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 5, 2022, the Company issued a press release announced the promotion of Ms. Vaknin as the Company&#8217;s new Chief Financial Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K, is incorporated herein by reference. The information
in this Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed to be &#8220; filed&#8221; for the purposes of Section
18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not
be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<i>Exhibits</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; width: 0.1in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Employment Agreement with Rachel Vaknin</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MICROBOT
    MEDICAL INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Harel Gadot</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President and Chairman</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 5, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZF02CuujSoiJWkSLiNthRgm2mTFJ/juQtjS3iMDAM733vCZGKFS1tjQyneVnAAZu2NgGhxAsyujNGR77eZBBviVfrAxsX+vcH5hQZjMx0pPQ5Cr31bj1WGcjJWM7GWoPSmVSw34rkq+fkLrZCF6ypwbgK9kwtWwyGX0PCwTzJUfPqq47I3pLLQI3kIL9BS6VhR3fzIL55KIpcJGk/iVgxde23pvOBGljU2MQuP6D/TT4UbElD -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;<IMG SRC="ex99-1_01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Microbot
Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Company
Continues to Enhance Core Capabilities to Ensure Commercial and Financial Success</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HINGHAM,
Mass., April 6, 2022</B> &ndash;Microbot Medical Inc. (Nasdaq: MBOT), seeking to continuously enhance its core capabilities, today
announced the promotion of Rachel Vaknin as its Chief Financial Officer. Ms. Vaknin, a seasoned finance executive with 20 years
of experience, joined the Company in January 2022 as VP Finance, and has replaced David Ben Naim as the Company&rsquo;s CFO effective
April 1, 2022. She will report directly to Harel Gadot, the Company&rsquo;s Chairman, President and CEO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Vaknin will be responsible for the Company&rsquo;s global finance, including financial planning and analysis, investor relations and
tax. Her addition to the Microbot Medical team reflects the Company&rsquo;s commitment to enhancing its core capabilities. Prior to joining
Microbot Medical, she was the CFO for a company in the autonomous driving sector and some of her primary duties included budget planning
and forecasts, preparation for financial due diligences and fundraising. From 2004 to 2016, she has held various finance roles of increasing
importance for Mellanox Technologies Ltd., a multinational supplier of computer networking products based on InfiniBand and Ethernet
technology, and prior to that she worked at BDO &ndash; Ziv &amp; Haft, a leading worldwide accounting firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Concurrent
with the progression and success of our operating goals, including recent pre-clinical and regulatory achievements, we have also sought
to strengthen critical roles within the organization to ensure we are positioned for future success,&rdquo; commented Mr. Gadot. &ldquo;I
am excited to have Rachel join our leadership team and help build out critical infrastructure needs to support our future commercialization
efforts. I believe her financial expertise, in addition to her track record leading finance functions and operations, will strongly support
our business objectives over the next few years. I also want to thank David for his many contributions over the past and we wish him
success in his future endeavors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Microbot
Medical is seeking to transform the surgical robotics market, and I believe the achievements over the past few months demonstrate the
Company is making great strides to achieve this goal,&rdquo; commented Ms. Vaknin. &ldquo;I am looking forward to working with Harel
and the rest of the team to ensure Microbot&rsquo;s continued success.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
Ben Naim had served as CFO on a part-time basis since 2016. The Company thanks Mr. Naim for his commitment to Microbot and wishes him
the best in his future endeavors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Microbot Medical Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies,
focused primarily on both natural and artificial lumens within the human body. Microbot&rsquo;s current proprietary technological platforms
provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for
patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available
at http://www.microbotmedical.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities
for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or
prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that
contain words such as &ldquo;will,&rdquo; &ldquo;believes,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects&rdquo;
and &ldquo;estimates&rdquo;) should also be considered to be forward-looking statements. Forward-looking statements involve risks and
uncertainties, including, without limitation, market conditions, risks inherent in the development and/or commercialization of potential
products, including LIBERTY and SCS, the outcome of its studies to evaluate LIBERTY, SCS and other existing and future technologies,
uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting
from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information
on risks facing Microbot Medical can be found under the heading &ldquo;Risk Factors&rdquo; in Microbot Medical&rsquo;s periodic reports
filed with the Securities and Exchange Commission (SEC), which are available on the SEC&rsquo;s web site at www.sec.gov. Microbot Medical
disclaims any intent or obligation to update these forward-looking statements, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
Polyviou</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC
Group</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mpolyviou@evcgroup.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">732-933-2754</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
November 22, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:
Ms. Rachel Vaknin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Rachel,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whereas,
Microbot Medical Ltd. (the &ldquo;<B>Company</B>&rdquo;) wishes to employ you according to the provisions of this letter agreement (this
&ldquo;<B>Agreement</B>&rdquo;), and you desire to be so employed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -70.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now,
therefore, you and the Company hereby agree to the following terms and conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Position
                                            and Scope of Position and Working Hours</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            shall be employed by the Company in the position, scope of position and days and hours of
                                            work as set forth in Annex A attached hereto and incorporated herein (&ldquo;<B><U>Annex
                                            A</U></B>&rdquo;), and your responsibilities, duties and tasks of such employment shall be
                                            determined and assigned to you, from time to time, by the supervisor set forth in <B><U>Annex
                                            A</U></B> (the &ldquo;<B>Supervisor</B>&rdquo;) or by any person that may be appointed by
                                            the Supervisor.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            shall perform your duties hereunder at the Company&rsquo;s facilities in Yokneam Illit, Israel;
                                            however, it is hereby agreed that you may work from time to time remotely from your home
                                            residence or any other place approved by the Supervisor, as shall be determined by the Company
                                            according to its needs and its sole discretion. In addition, you acknowledge and agree that
                                            the performance of your duties hereunder may require domestic or international travel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Term
                                            and Termination</U></B></FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                    <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">2.1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">The
  term of your employment shall commence on the date set forth in <B><U>Annex A</U></B> (the &ldquo;<B>Effective Date</B>&rdquo;) and
  shall continue for an unlimited term unless terminated either by you or by the Company, at any time and for any reason, by providing
  prior written notice as set forth in <B><U>Annex A,</U></B> except for in the event of a Termination for Cause.</TD></TR>
                                                                                    <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                    <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">2.2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">In
                                            the event of any termination which is not a Termination for Cause, the Company shall be entitled
                                            to terminate your employment immediately or at any time during the prior notice period referenced
                                            above, <I>provided however</I>, that in such an event the Company shall pay you your applicable
                                            prior notice redemption.</TD></TR>
                                                                                    </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that you shall voluntarily resign, without providing the Company the full prior notice as set forth in <B><U>Annex A</U></B>,
you shall be required to pay the Company the value of the prior notice not provided by you, and said value shall be deemed a debt of
you towards the Company. Notwithstanding the aforesaid, the Company shall be entitled to deduct and set-off any amounts due to it in
this respect from any amounts payable or due to you by the Company and you irrevocably instruct the Company to make such deductions and
set-offs and confirm that your consent is in accordance with the provisions of the Wage Protection Law-1958.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot Medical
LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
                                            anything to the contrary in this Agreement, the Company shall be entitled to terminate your
                                            employment immediately, without prior notice or the redemption thereof, in the event that
                                            you commit any of the following: embezzlement; theft; any other criminal offence involving
                                            moral turpitude; breach of a fiduciary duty or duty or loyalty; a willful failure to perform
                                            your responsibilities or duties, a material breach of this Agreement, including without limitation
                                            a breach of any of your undertakings as set forth in Annex B attached hereto and incorporated
                                            herein (&ldquo;<B><U>Annex B</U></B>&rdquo;) and/or your representation in Section 4.9 below;
                                            and/or any other act or omission which under applicable law enable(s) entire and/or partial
                                            denial of severance payments or prior notice or redemption thereof (&ldquo;<B>Termination
                                            for Cause</B>&rdquo;).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            undertake that in the event you cease to work for the Company, for any reason whatsoever,
                                            you immediately upon such termination will transfer any and all assets and/or other property
                                            of the Company that may be in your possession, including without limitation all Company cars,
                                            telephones, computers, employee identification cards, keys, equipment, property, information
                                            and documents held and/or prepared by you in the framework of your employment with the Company
                                            to whomever the Company shall determine, in an organized, timely and appropriate manner.
                                            You further undertake that upon such termination, you will cease to present yourself as a
                                            Company employee in any and all media platforms, including internet websites, social networks,
                                            and/or social applications.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is hereby clarified that if any asset and/or other property of the Company is placed at your
                                            disposal, you have limited rights with respect to the use of such an item during and for
                                            purposes of your employment with Company only, and you shall not have the right to any lien,
                                            security interest or encumbrance with respect thereto and you hereby waive all such rights.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Compensation
                                            and Benefits</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Salary</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -32.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You shall be entitled to a base salary in
  a gross monthly amount as set forth in <B><U>Annex A</U></B> (the &ldquo;<B>Base Salary</B>&rdquo;) and a monthly gross global compensation
  for the performance of overtime hours in the amount as set forth in <B><U>Annex A</U></B> (the &ldquo;<B>Global Compensation</B>&rdquo;)
  <B>&ndash;</B> which together shall be referred to herein as the &ldquo;<B>Salary</B>&rdquo;.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Salary shall be paid to you by the 9<SUP>th</SUP> (ninth) day of the month following the
                                            month for which it is due.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is hereby clarified that if you elect to have a leased car, then a total amount of NIS 3,000
                                            shall be reduced from your Salary (as further detailed in <B><U>Annex A</U></B>), and the
                                            amount following said reduction (the &ldquo;<B>Adjusted Salary</B>&rdquo;) will be deemed
                                            your updated Salary, for all intents and purposes (including for the calculation of any rights
                                            hereunder or for any purpose whatsoever, including without limitation, pension insurance
                                            and severance pay, education fund, sick days and vacation days) and all relevant aspect in
                                            this Agreement shall be recalculated as per the Adjusted Salary accordingly.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Vacation,
                                            Recreation Pay, Sick Leave and Reserve Duty</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            shall be entitled to such a number of paid vacation days annually as set forth in <B><U>Annex
                                            A</U></B>. Procedures of the utilization and redemption of vacation days shall be as prescribed
                                            by applicable law and in coordination with the Supervisor with reasonable consideration to
                                            the needs of the Company. Notwithstanding anything to the contrary in this Agreement, you
                                            shall make all efforts to use your entire allotment of annual vacation days by the end of
                                            any calendar year, however, if you are unable to do so, you shall be entitled to accumulate
                                            the unused balance of such vacation days up to a maximum amount set forth in <B><U>Annex
                                            A</U></B> (&ldquo;<B>Maximum Quota</B>&rdquo;). For the avoidance of doubt, any unused vacation
                                            days in excess of the Maximum Quota shall be canceled and are not redeemable in any manner.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot Medical
LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -28.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            shall be entitled to &ldquo;dmei havra&rsquo;a&rdquo; (&ldquo;<B>Recreation Pay</B>&rdquo;)
                                            and sick days as set forth in <B><U>Annex A</U></B>.<B>&#9;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            shall be entitled to payment during reserve duty in accordance with the provisions of applicable
                                            laws.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Pension
                                            and Severance Pay</U></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall pay, and shall deduct from the Salary, on a monthly basis, as premiums for
                                            a manager&rsquo;s insurance policy and/or pension fund and/or a combination of the two (the
                                            &ldquo;<B>Policy</B>&rdquo;), chosen by you, amounts equal to the percentages of the Salary
                                            set forth in <B><U>Annex A</U></B>.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                            sums contributed by you shall be deducted from your Salary at source, and you hereby irrevocably
                                            instruct and authorize the Company to make such deductions and transfers to the Policy.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the above,
  you are entitled to instruct the Company in writing to distribute the payments and contributions described above among different and
  various policies and saving plans, at your discretion, so long as the Company&rsquo;s total costs and liabilities in connection with
  said payments and contributions (and the funds and rights associated with and/or accrued therewith) will not exceed the amounts referenced
  herein; all subject to any applicable law and/or instructions and/or guidelines of the Ministry of Finance and/or all the by-laws and
  regulations of any fund and/or the provisions of the Extension Order regarding the enlargement of pension contributions, all as shall
  be in effect from time to time.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is hereby expressly agreed
  that the Company&rsquo;s contribution for severance pay of eight and one-thirds percent (8.33%) together with any linkage, interest
  or other profit derivative thereof shall be <B>instead of</B> your severance compensation, should you be entitled thereto, such that
  upon release of the Policy to you, no additional calculations shall be conducted regarding the matter of severance pay and no additional
  payments shall be made by the Company to you.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You and the Company hereby
  adopt the provisions of the &ldquo;General Order and Confirmation Regarding Payments of Employers to Pension Funds and Insurance Funds
  instead of Severance Pay&rdquo; pursuant to Section 14 of the Severance Pay Law<B>-</B>1963, attached hereto as <B><U>Annex A-1</U></B>,
  or any amended provisions of said General Order as shall be in effect from time to time.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company waives all rights
  to have its payment to the Policy refunded, unless your right to severance payment has been negated, in a decision of a competent court,
  pursuant to Section 16 or 17 of the Severance Pay Law <B>-</B> 1963, and to the extent so negated, or in the event in which you shall
  have withdrawn funds from the Policy other than for an &lsquo;entitling event&rsquo; (i.e. death, invalidity, or retirement at the
  age of 60 or older).</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot Medical
LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You shall bear any and all
  taxes which may apply with respect to any contribution which exceeds the recognized tax ceilings.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Study
  Fund</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall contribute, and shall deduct from your Salary, on a monthly basis, towards
                                            a &ldquo;keren hishtalmut&rdquo; (&ldquo;<B>Study Fund</B>&rdquo;), chosen by you, amounts
                                            equal to the percentages of the Salary set forth in <B><U>Annex A</U></B>. The sums contributed
                                            by you shall be deducted from your Salary at source, and you hereby irrevocably instruct
                                            and authorize the Company to make such deductions and transfer to the Study Fund. It is hereby
                                            clarified and agreed that you shall bear any and all taxes which may apply with respect to
                                            any contributions which exceed the recognized tax ceiling.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            the termination of your employment with the Company for any reason whatsoever, the Company
                                            shall release to you all the amounts accumulated in the Study Fund.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commuting
                                            Expenses Reimbursement or Car</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the term of your employment, you shall be entitled to reimbursement of commuting expenses for commuting to work and from work, or to
a leased car, subject to your discretion, in accordance with the terms set forth in <B><U>Annex A</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Annual
  Bonus</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may be eligible to receive an annual bonus in the aggregate amount of up to twenty percent
                                            (20%) of the annual salary, contingent upon meeting certain targets, as shall be determined
                                            from time to time by the Company, at its sole discretion (the &ldquo;<B>Bonus</B>&rdquo;).
                                            It is hereby clarified that the Company shall have the sole discretion regarding the decision
                                            whether you have achieved the goals which were set to you.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Bonus, to the extent due, shall be paid to you in a lump sum together with the Salary at
                                            the beginning of the following calendar year, as shall be determined by the Company, subject
                                            to you being employed by the Company at its date of payment.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is hereby agreed, that the Bonus shall not be deemed an integral part of your Salary for
                                            any purpose whatsoever, including for the purposes of calculating your social benefits, such
                                            as severance pay, contributions to manager&rsquo;s insurance/pension fund, vacation, etc.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Options</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to and contingent upon the future recommendation of the Compensation Committee of Microbot
                                            Medical Inc. (the &ldquo;<B>Parent Company</B>&rdquo;) and the approval Board of Directors
                                            of the Parent Company (together shall be referred to as the &ldquo;<B>Parent&rsquo;s Board</B>&rdquo;),
                                            the Parent Company may grant you such number of options to purchase shares of Common Stock
                                            of the Parent Company (the &ldquo;<B>Options</B>&rdquo;). The number of Options, exercise
                                            price and vesting schedule shall be determined by the Parent&rsquo;s Board at its sole discretion.
                                            All other terms of the Options, including, without limitation, with respect to the expiration
                                            of the Options upon the termination of employment shall be subject to the provisions of the
                                            Company&rsquo;s 2020 Omnibus Performance Award Plan (the &ldquo;<B>Plan</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot Medical
LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is clarified that the Options shall only be granted to you subject to and following: (i)
                                            the specific resolution and approval of the Parent&rsquo;s Board with respect to such grant;
                                            (ii) the execution by you of all documentation required for this purpose; and (iii) all other
                                            terms and conditions regarding the Options, as determined in the Plan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is further clarified that you shall be solely responsible for and shall bear all tax and/or
                                            other mandatory payments and/or consequences arising from the grant and/or exercise of the
                                            Options and/or the transfer or sale of the shares of Common Stock issued pursuant to the
                                            exercise thereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Meals</U></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall participate in the cost of meals in the amount of up to NIS 40 per working
                                            day, in accordance with the Company policy, as in effect from time to time.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            is hereby clarified that you shall bear any and all taxes applicable to you resulting from
                                            the value of the meals participation according to the tax regulations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B>.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Obligations and Undertakings</U></B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"></TD>
  <TD STYLE="text-align: justify">You <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">undertake
  as follows:</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            have the ability and the skills to carry out the duties of your position and perform the
                                            services as set forth in this Agreement, and you will devote your entire working time, attention,
                                            energies, talents, skills, knowledge and experience to the performance of your duties and
                                            responsibilities hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the term of your employment, you will not, without the prior written consent of the Company,
                                            directly or indirectly, engage in any other professional or business activity or occupation,
                                            whether paid or unpaid; and you shall not receive, directly or indirectly, any compensation
                                            or benefit of any kind in connection with your work for the Company from any source except
                                            as set forth in this Agreement; and you shall notify the Company immediately in writing regarding
                                            any matter in which you have a personal interest and which may potentially create a conflict
                                            of interest between you and your work for the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You shall maintain confidentiality,
  assign intellectual property rights and you shall refrain from competing with and/or soliciting from the Company, including without
  limitation according to the undertakings attached hereto as <B><U>Annex B</U></B>. Without derogating from the generality of the foregoing,
  you are aware that the terms of this Agreement are personal and specific to you and that the maintenance of their confidentiality is
  of utmost importance to the Company, and you undertake to maintain the confidentiality of the terms of your employment hereunder, and
  not disclose them to any other individual or entity. You understand that your agreement to these undertakings, and specifically to
  the provisions of Annex B, are a material inducement for the Company to enter into this Agreement.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The execution and delivery
  of this Agreement and the performance of the terms hereof: (a) shall not constitute a default under or breach of any agreement or other
  understanding to which you are a party or by which you are bound, including without limitation any confidentiality or non-competition
  agreement; (b) is not prohibited under any law, regulation or court order; and (c) does not require the consent of any other individual
  or entity.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You consent, of your own
  free will and although not required to do so under law, that the information in this Agreement and any information concerning you gathered
  by the Company, will be held and managed by the Company or on its behalf, including without limitation on databases according to law,
  and that the Company shall be entitled to transfer such information to third parties, in Israel or abroad. The Company undertakes that
  the information will be used and transferred for legitimate business purposes only, while undertaking reasonable commercial efforts
  to maintain your right to privacy.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            agree that the Company and any related entity may, for any business purpose (including security
                                            and protecting their legitimate interests), monitor your use of their Communications Systems
                                            and copy, transfer and disclose all electronic communications and content transmitted by
                                            or stored in such Communications Systems, regardless of the location or time of such use
                                            in accordance with the Company&rsquo;s policy as shall be in effect from time to time. For
                                            the purposes of this Section, &ldquo;Communications Systems&rdquo; means Company&rsquo;s
                                            computer, laptop, computer system, internet server, electronic database, hardware, software
                                            and e-mail account, whether under your direct control or otherwise. You may use the Company&rsquo;s
                                            systems for business purposes solely, and shall not make any personal use in them (unless
                                            you clearly define and mark your personal information stored in the Communications Systems
                                            as &ldquo;Personal&rdquo;), all subject to Company&rsquo;s policy as in effect from time
                                            to time. For personal use, you may use external e-mail services (i.e. Gmail, Yahoo mail etc.).
                                            Upon the Company&rsquo;s request, you shall transfer to the Company your log-on passwords
                                            and details to the Company&rsquo;s e-mail, computer and other accounts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            hereby agree that the Company has a legitimate business need to place visible cameras at
                                            Company&rsquo;s offices for security, discipline and protection of the Company&rsquo;s Confidential
                                            Information (as such term is defined in Annex B); all subject to Company&rsquo;s policies
                                            in this respect as shall be in effect from time to time.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You shall comply with all
  laws and regulations governing your employment and the Company&rsquo;s policies, procedures and objectives as shall be in effect from
  time to time, including without limitation regarding the prevention of sexual harassment, and you shall cooperate with the Company
  in maintaining an authentic record of the number of working hours performed by you.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            hereby represent that the information you provided the Company with about yourself, your
                                            education, experience and/or skills and qualifications, during your recruiting procedure,
                                            including without limitation in your resume, was true, complete and accurate. You hereby
                                            declare and agree that breach of this Section 4.9 shall, <I>inter alia</I>, be deemed a fundamental
                                            breach of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You are aware and confirm
  that without your agreement to the undertakings of this Section 4, the Company would not enter this Agreement with you.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Miscellaneous</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            preamble to this Agreement, and the annexes hereto, constitute integral parts of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The addresses of you or the
  Company for the purposes of this Agreement will be as set forth below, or as either you or the Company may advise the other in writing,
  and any notice which is sent via registered mail by you or the Company to the other party at such address, will be deemed received
  by the addressee 72 hours after it was sent for delivery at a post office in Israel. If notices shall be delivered by hand, they will
  be deemed received at the time at which they were delivered; and if by e-mail &ndash; 24 hours after it was sent.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any modification of or addition
  to this Agreement shall be valid only if in writing and signed by both you and the Company.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement is personal and special and exclusively delineates the entire relationship between
                                            the Company and yourself, and contains all compensation and/or benefits and/or other conditions
                                            of any kind to which you are entitled from the Company, as an employee thereof, and supersedes
                                            all prior agreements, understandings, negotiations, promises, consents, undertakings, representations,
                                            warranties, oral or written, exchanged or signed between the Company and yourself with respect
                                            to the subject matter hereof. No general and/or special collective agreements apply to your
                                            employment hereunder. For the removal of any doubt and without derogating from the above,
                                            in the event that with respect to any of the matters addressed herein, provisions of law,
                                            collective agreements and/or extension orders shall, notwithstanding the above, apply to
                                            you, the provisions of this Agreement shall be deemed as coming in their stead, or at least,
                                            as being on account of said applicable provisions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            taxes applicable to any and all compensation to be paid to you or benefits granted to you
                                            under this Agreement, including taxes which may apply with respect to any contributions which
                                            exceed the recognized tax ceilings <B>-</B> shall be borne exclusively by you. The Company
                                            shall deduct and withhold income tax, health insurance and national insurance from your gross
                                            income, and any other deductions or withholdings that may be required from time to time,
                                            pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement is in lieu of the &ldquo;Notice of Terms of Employment&rdquo; pursuant to the Notice
                                            To the Employee and Job Candidate Law (Employment Conditions and Candidate Screening and
                                            Selection)-2002.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
                                            Agreement shall be interpreted and construed in accordance with the laws of the State of
                                            Israel. All disputes arising from this Agreement shall be exclusively commenced in the competent
                                            courts of the State of Israel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
look forward to working with you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Microbot
    Medical Ltd.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/ Naama Moav</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">HR Director</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company&rsquo;s Registration no. </FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">514519412 <FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company&rsquo;s Address: </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">6 Hayozma St, Yokneam Illit.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
indicate your understanding and acceptance of the provisions, terms and obligations set forth in this Agreement including without limitation
the annexes hereto, please affix your name, ID number, address and signature in the space provided below and in the attached annexes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/ Rachel Vaknin</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Rachel Vaknin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ID:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">22/11/2021</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex10-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ANNEX
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>to
the Agreement between Rachel Vaknin and Microbot Medical Ltd. (the &ldquo;Company&rdquo;), dated</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>November___,
2021</U></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personal
    Details</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
                                            Name: Rachel Vaknin</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.D.
    Number: _______________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
    ___________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone
    Number (cell): +972-____________</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position
    in the Company</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VP
    Finance</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supervisor</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company&rsquo;s
    CEO</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scope
    of Position </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    time position.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Days
    and Hours of Work </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            regular working week shall be 42 hours; the regular working days shall be Sunday&ndash;Thursday,
                                            of which 4 days shall consist of 8.6 net hours per day (not including a lunch break on your
                                            account), and one day, as shall be determined by the Company, shall consist of 7.6 net hours
                                            (not including a lunch break on your account).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saturday
    shall be your rest day.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
    Salary (gross)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIS
    32,000 per month.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
    Compensation (gross)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition to the regular working days and hours, you may be required to be available to work
                                            at unusual and flexible extra hours and on irregular days.</FONT></P>
                                                                              <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Therefore,
    you shall be paid on a monthly basis, in addition to your Base Salary, a Global Compensation in the amount of NIS 8,000 per month
    for a monthly average of <B>35</B> overtime hours, which has been determined according to a reasonable estimation of the overtime
    hours that you will be required to work.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    are not authorized to, and shall not, work more than the quota of overtime hours mentioned above in any month without the prior written
    consent of the Company.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Global Compensation reflects your full compensation for the performance of work during overtime hours.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
    although the Global Compensation is and shall be a real and true supplement above and beyond your Base Salary and the Company does
    not have a legal obligation to do so, the Company shall &ndash; <I>ex gratia</I> &ndash; take into account the Global Compensation
    for the purpose of calculating your social benefits and rights according to this Agreement, and the Global Compensation shall be
    paid to you also in the case of your absence from work due to vacation, sickness, or reserve duty.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary
    (gross)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIS
                                            40,000 per month.</FONT></P>
                                                                              <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the event you shall request to receive a leased car, as of the date in which it shall be placed at your disposal, your Salary shall
    be reduced to the Adjusted Salary, in the amount of NIS 37,000 (gross) per month (i.e. Base Salary- NIS 29,600 and Global Compensation-
    NIS 7,400).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is clarified and agreed that your Salary was calculated to include a special consideration, which equals 10% of the Salary, for your
    non-competition undertakings as detailed in <B><U>Annex B</U></B>.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vacation
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            the first year of your employment - 22 business days per annum.</FONT></P>
                                                                              <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    the second year of your employment &ndash; 23 business days per annum.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of the third year of your employment &ndash; 24 business days per annum.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    is hereby clarified that the above shall not constitute an undertaking to a minimal term of employment.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall be entitled to set uniform dates for its employees&rsquo; vacation, with respect to all or any part of the vacation
    days, as it shall deem fit, including during the intermediate holidays.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Quota - equals to 24 vacation days.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commuting
    Expenses<BR>
Reimbursement or Leased Car</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            shall be entitled to reimbursement of commuting expenses in the amount of NIS 1,000 per month.</FONT></P>
                                                                              <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding,
    you may be entitled to opt to receive, in lieu of the commuting expenses reimbursement, a leased car of a model according to the
    Company&rsquo;s standards, for your business and personal use (the &ldquo;<B>Car</B>&rdquo;). All expenses incurred in connection
    with the use of the Car, including insurance, maintenance and repairs, shall be borne and paid by the Company, excluding fines and
    tickets.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    shall bear the tax usage value incurred in connection with the Car, as shall be in effect from time to time.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    will drive the Car carefully and properly qua an owner who cares for his/her property and according to the Company&rsquo;s applicable
    policy as in effect from time to time.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    confirm that excluding the right to use the Car, you shall not have any interest, lien, encumbrance or retention or other right in
    the Car and you undertake to return the Car in good condition immediately to the Company upon the termination of your employment.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the avoidance of doubt, it is hereby clarified that the Car shall be provided in lieu of any payment in respect of commuting expenses.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recreation
    Pay</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with the applicable law.</FONT></P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sick
    Days</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with the applicable law, subject to the submission of medical certificates, no
                                            later than three (3) days from your absence.</FONT></P>
                                                                              <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of 1.5 sick days for each month of full-time work (meaning 18 days per year); however, not accumulate more than 90 days over time.</FONT></P></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot Medical
LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension and Severance Pay</FONT></TD>
    <TD STYLE="width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company&rsquo;s Contribution
    to Severance</B></FONT></TD>
    <TD STYLE="width: 19%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company&rsquo;s Contribution
    to Pension and Life Insurance*</B></FONT></TD>
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Your Contribution to Pension
    and Life Insurance</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.33%</FONT></P>
    <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5%</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6%</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0pt 0pt 2.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">* In the event that you shall elect to be insured in a managers insurance
policy or a provident fund which is not a pension fund -&nbsp;the&nbsp;Company's contributions towards pension and life insurance shall
include payment for disability insurance in an amount which will ensure 75% of the Salary, <I>provided however</I>, that in any event
the contributions of the Company towards life insurance and pension shall be equal to at least 5% of the Salary, and the total cost of
the Company for disability insurance and pension and life insurance shall not exceed 7.5% of the Salary.</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">Name of the Policy</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">_____________</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">Starting Date</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">_____________</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 18%; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Study
                                            Fund</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company&rsquo;s
                                            Contribution</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Your
                                            Contribution</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5%</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5%</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of the Policy</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Starting
    Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;Effective
    Date</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    __, 2021</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.6in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.71in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
    Notice Period</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60
    days. &nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; direction: rtl; unicode-bidi: embed; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>/s/
    Naama Moav</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; direction: rtl; unicode-bidi: embed; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>/s/
    Rachel Vaknin</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: rtl; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Microbot
    Medical Ltd.</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; direction: rtl; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rachel
    Vaknin</B></FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -1.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ANNEX
A-1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>&#1488;&#1497;&#1513;&#1493;&#1512;
&#1499;&#1500;&#1500;&#1497; &#1489;&#1491;&#1489;&#1512; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497; &#1502;&#1506;&#1489;&#1497;&#1491;&#1497;&#1501;
&#1500;&#1511;&#1512;&#1503; &#1508;&#1504;&#1505;&#1497;&#1492; &#1493;&#1500;&#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495;
&#1489;&#1502;&#1511;&#1493;&#1501; &#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501;<SUP>[1]
</SUP>&#1500;&#1508;&#1497; &#1495;&#1493;&#1511; &#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501;,
&#1492;&#1514;&#1513;&#1499;&rdquo;&#1490; - 1963</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1489;&#1514;&#1493;&#1511;&#1507;
&#1505;&#1502;&#1499;&#1493;&#1514;&#1497; &#1500;&#1508;&#1497; &#1505;&#1506;&#1497;&#1507; 14 &#1500;&#1495;&#1493;&#1511; &#1508;&#1497;&#1510;&#1493;&#1497;&#1497;
&#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501;, &#1492;&#1514;&#1513;&#1499;&rdquo;&#1490; - 1963<SUP>[2]</SUP> (&#1500;&#1492;&#1500;&#1503;
- &#1492;&#1495;&#1493;&#1511;), &#1488;&#1504;&#1497; &#1502;&#1488;&#1513;&#1512; &#1499;&#1497; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501;
&#1513;&#1513;&#1497;&#1500;&#1501; &#1502;&#1506;&#1489;&#1497;&#1491; &#1492;&#1495;&#1500; &#1489;&#1497;&#1493;&#1501; &#1508;&#1512;&#1505;&#1493;&#1502;&#1493;
&#1513;&#1500; &#1488;&#1497;&#1513;&#1493;&#1512; &#1494;&#1492;, &#1489;&#1506;&#1491; &#1506;&#1493;&#1489;&#1491;&#1493; &#1500;&#1508;&#1504;&#1505;&#1497;&#1492;
&#1502;&#1511;&#1497;&#1508;&#1492; &#1489;&#1511;&#1493;&#1508;&#1514; &#1490;&#1502;&#1500; &#1500;&#1511;&#1497;&#1510;&#1489;&#1492;
&#1513;&#1488;&#1497;&#1504;&#1492; &#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495; &#1499;&#1502;&#1513;&#1502;&#1506;&#1493;&#1514;&#1492;
&#1489;&#1514;&#1511;&#1504;&#1493;&#1514; &#1502;&#1505; &#1492;&#1499;&#1504;&#1505;&#1492; (&#1499;&#1500;&#1500;&#1497;&#1501; &#1500;&#1488;&#1497;&#1513;&#1493;&#1512;
&#1493;&#1500;&#1504;&#1497;&#1492;&#1493;&#1500; &#1511;&#1493;&#1508;&#1493;&#1514; &#1490;&#1502;&#1500;), &#1492;&#1514;&#1513;&#1499;&rdquo;&#1491;
- 1964<SUP>[3]</SUP> (&#1500;&#1492;&#1500;&#1503; - &#1511;&#1512;&#1503; &#1508;&#1504;&#1505;&#1497;&#1492;), &#1488;&#1493; &#1500;&#1489;&#1497;&#1496;&#1493;&#1495;
&#1502;&#1504;&#1492;&#1500;&#1497;&#1501; &#1492;&#1499;&#1493;&#1500;&#1500; &#1488;&#1508;&#1513;&#1512;&#1493;&#1514; &#1500;&#1511;&#1497;&#1510;&#1489;&#1492;
&#1488;&#1493; &#1513;&#1497;&#1500;&#1493;&#1489; &#1513;&#1500; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501; &#1500;&#1514;&#1499;&#1504;&#1497;&#1514;
&#1511;&#1510;&#1489;&#1492; &#1493;&#1500;&#1514;&#1499;&#1504;&#1497;&#1514; &#1513;&#1488;&#1497;&#1504;&#1492; &#1500;&#1511;&#1510;&#1489;&#1492;
&#1489;&#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495; &#1499;&#1488;&#1502;&#1493;&#1512; (&#1500;&#1492;&#1500;&#1503;
- &#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495;), &#1500;&#1512;&#1489;&#1493;&#1514; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501;
&#1513;&#1513;&#1497;&#1500;&#1501; &#1514;&#1493;&#1498; &#1513;&#1497;&#1500;&#1493;&#1489; &#1513;&#1500; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501;
&#1500;&#1511;&#1512;&#1503; &#1508;&#1504;&#1505;&#1497;&#1492; &#1493;&#1500;&#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495;,
&#1489;&#1497;&#1503; &#1488;&#1501; &#1497;&#1513; &#1489;&#1511;&#1493;&#1508;&#1514; &#1492;&#1489;&#1497;&#1496;&#1493;&#1495; &#1514;&#1499;&#1504;&#1497;&#1514;
&#1500;&#1511;&#1510;&#1489;&#1492; &#1493;&#1489;&#1497;&#1503; &#1488;&#1501; &#1500;&#1488;&#1493; (&#1500;&#1492;&#1500;&#1503; -
&#1514;&#1513;&#1500;&#1493;&#1502;&#1497; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491;), &#1497;&#1489;&#1493;&#1488;&#1493; &#1489;&#1502;&#1511;&#1493;&#1501;
&#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1492;&#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501; &#1492;&#1502;&#1490;&#1497;&#1506;&#1497;&#1501;
&#1500;&#1506;&#1493;&#1489;&#1491; &#1492;&#1488;&#1502;&#1493;&#1512; &#1489;&#1490;&#1497;&#1503; &#1492;&#1513;&#1499;&#1512; &#1513;&#1502;&#1502;&#1504;&#1493;
&#1513;&#1493;&#1500;&#1502;&#1493; &#1492;&#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501; &#1492;&#1488;&#1502;&#1493;&#1512;&#1497;&#1501;
&#1493;&#1500;&#1514;&#1511;&#1493;&#1508;&#1492; &#1513;&#1513;&#1493;&#1500;&#1502;&#1493; (&#1500;&#1492;&#1500;&#1503; - &#1492;&#1513;&#1499;&#1512;
&#1492;&#1502;&#1493;&#1508;&#1496;&#1512;), &#1493;&#1489;&#1500;&#1489;&#1491; &#1513;&#1504;&#1514;&#1511;&#1497;&#1497;&#1502;&#1493;
&#1499;&#1500; &#1488;&#1500;&#1492;:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1514;&#1513;&#1500;&#1493;&#1502;&#1497;
                                            &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; -</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#1488;)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1500;&#1511;&#1512;&#1503;
                                            &#1508;&#1504;&#1505;&#1497;&#1492; &#1488;&#1497;&#1504;&#1501; &#1508;&#1495;&#1493;&#1514;&#1497;&#1501;
                                            &#1502;- <SUP>1</SUP>/<SUB>3</SUB> 14 &#1502;&#1503; &#1492;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;
                                            &#1488;&#1493; 12% &#1502;&#1503; &#1492;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;
                                            &#1488;&#1501; &#1502;&#1513;&#1500;&#1501; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1489;&#1506;&#1491;
                                            &#1506;&#1493;&#1489;&#1491;&#1493; &#1489;&#1504;&#1493;&#1505;&#1507; &#1500;&#1499;&#1498;
                                            &#1499;&#1498; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501; &#1500;&#1492;&#1513;&#1500;&#1502;&#1514;
                                            &#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501;
                                            &#1500;&#1511;&#1493;&#1508;&#1514; &#1490;&#1502;&#1500; &#1500;&#1508;&#1497;&#1510;&#1493;&#1497;&#1497;&#1501;
                                            &#1488;&#1493; &#1500;&#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495; &#1506;&#1500;
                                            &#1513;&#1501; &#1492;&#1506;&#1493;&#1489;&#1491; &#1489;&#1513;&#1497;&#1506;&#1493;&#1512;
                                            &#1513;&#1500; % <SUP>1</SUP>/<SUB>3</SUB> 2 &#1502;&#1503; &#1492;&#1513;&#1499;&#1512;
                                            &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;. &#1500;&#1488; &#1513;&#1497;&#1500;&#1501; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491;
                                            &#1489;&#1504;&#1493;&#1505;&#1507; &#1500;12%- &#1490;&#1501; % <SUP>1</SUP>/<SUB>3</SUB>
                                            2 &#1499;&#1488;&#1502;&#1493;&#1512;, &#1497;&#1489;&#1493;&#1488;&#1493; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1493;
                                            &#1489;&#1502;&#1511;&#1493;&#1501; 72% &#1502;&#1508;&#1497;&#1510;&#1493;&#1497;&#1497;
                                            &#1492;&#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501; &#1513;&#1500; &#1492;&#1506;&#1493;&#1489;&#1491;,
                                            &#1489;&#1500;&#1489;&#1491;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#1489;)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1500;&#1511;&#1493;&#1508;&#1514;
                                            &#1489;&#1497;&#1496;&#1493;&#1495; &#1488;&#1497;&#1504;&#1501; &#1508;&#1495;&#1493;&#1514;&#1497;&#1501;
                                            &#1502;&#1488;&#1495;&#1491; &#1502;&#1488;&#1500;&#1492;:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
                                            <SUP>1</SUP>/<SUB>3</SUB> 13 &#1502;&#1503; &#1492;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;,
                                            &#1488;&#1501; &#1502;&#1513;&#1500;&#1501; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1489;&#1506;&#1491;
                                            &#1506;&#1493;&#1489;&#1491;&#1493; &#1489;&#1504;&#1493;&#1505;&#1507; &#1500;&#1499;&#1498;
                                            &#1490;&#1501; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501; &#1500;&#1492;&#1489;&#1496;&#1495;&#1514;
                                            &#1492;&#1499;&#1504;&#1505;&#1492; &#1495;&#1493;&#1491;&#1513;&#1497;&#1514; &#1489;&#1502;&#1511;&#1512;&#1492;
                                            &#1488;&#1489;&#1491;&#1503; &#1499;&#1493;&#1513;&#1512; &#1506;&#1489;&#1493;&#1491;&#1492;,
                                            &#1489;&#1514;&#1499;&#1504;&#1497;&#1514; &#1513;&#1488;&#1497;&#1513;&#1512; &#1492;&#1502;&#1502;&#1493;&#1504;&#1492;
                                            &#1506;&#1500; &#1513;&#1493;&#1511; &#1492;&#1492;&#1493;&#1503; &#1489;&#1497;&#1496;&#1493;&#1495;
                                            &#1493;&#1495;&#1505;&#1499;&#1493;&#1503; &#1489;&#1502;&#1513;&#1512;&#1491; &#1492;&#1488;&#1493;&#1510;&#1512;,
                                            &#1489;&#1513;&#1497;&#1506;&#1493;&#1512; &#1492;&#1491;&#1512;&#1493;&#1513; &#1500;&#1492;&#1489;&#1496;&#1495;&#1514;
                                            75% &#1502;&#1503; &#1492;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;
                                            &#1500;&#1508;&#1495;&#1493;&#1514; &#1488;&#1493; &#1489;&#1513;&#1497;&#1506;&#1493;&#1512;
                                            &#1513;&#1500; % &frac12; 2 &#1502;&#1503; &#1492;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;,
                                            &#1500;&#1508;&#1497; &#1492;&#1504;&#1502;&#1493;&#1498; &#1502;&#1489;&#1497;&#1504;&#1492;&#1501;
                                            (&#1500;&#1492;&#1500;&#1503; - &#1514;&#1513;&#1500;&#1493;&#1501; &#1500;&#1489;&#1497;&#1496;&#1493;&#1495;
                                            &#1488;&#1489;&#1491;&#1503; &#1499;&#1493;&#1513;&#1512; &#1506;&#1489;&#1493;&#1491;&#1492;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 55.4pt 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11%
                                            &#1502;&#1503; &#1492;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;, &#1488;&#1501;
                                            &#1513;&#1497;&#1500;&#1501; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1489;&#1504;&#1493;&#1505;&#1507;
                                            &#1490;&#1501; &#1514;&#1513;&#1500;&#1493;&#1501; &#1500;&#1489;&#1497;&#1496;&#1493;&#1495;
                                            &#1488;&#1489;&#1491;&#1503; &#1499;&#1493;&#1513;&#1512; &#1506;&#1489;&#1493;&#1491;&#1492;,
                                            &#1493;&#1489;&#1502;&#1511;&#1512;&#1492; &#1494;&#1492; &#1497;&#1489;&#1493;&#1488;&#1493;
                                            &#1514;&#1513;&#1500;&#1493;&#1502;&#1497; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1489;&#1502;&#1511;&#1493;&#1501;
                                            72% &#1502;&#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1492;&#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501;
                                            &#1513;&#1500; &#1492;&#1506;&#1493;&#1489;&#1491;, &#1489;&#1500;&#1489;&#1491;; &#1513;&#1497;&#1500;&#1501;
                                            &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1489;&#1504;&#1493;&#1505;&#1507; &#1500;&#1488;&#1500;&#1492;
                                            &#1490;&#1501; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1501; &#1500;&#1492;&#1513;&#1500;&#1502;&#1514;
                                            &#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501;
                                            &#1500;&#1511;&#1493;&#1508;&#1514; &#1490;&#1502;&#1500; &#1500;&#1508;&#1497;&#1510;&#1493;&#1497;&#1497;&#1501;
                                            &#1488;&#1493; &#1500;&#1511;&#1493;&#1508;&#1514; &#1489;&#1497;&#1496;&#1493;&#1495; &#1506;&#1500;
                                            &#1513;&#1501; &#1492;&#1506;&#1493;&#1489;&#1491; &#1489;&#1513;&#1497;&#1506;&#1493;&#1512;
                                            &#1513;&#1500; % <SUP>1</SUP>/<SUB>3</SUB> 2 &#1502;&#1503; &#1492;&#1513;&#1499;&#1512;
                                            &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;, &#1497;&#1489;&#1493;&#1488;&#1493; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;
                                            &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1489;&#1502;&#1511;&#1493;&#1501; 100% &#1508;&#1497;&#1510;&#1493;&#1497;&#1497;
                                            &#1492;&#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501; &#1513;&#1500; &#1492;&#1506;&#1493;&#1489;&#1491;.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -42.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1500;&#1488;
                                            &#1497;&#1488;&#1493;&#1495;&#1512; &#1502;&#1513;&#1500;&#1493;&#1513;&#1492; &#1495;&#1493;&#1491;&#1513;&#1497;&#1501;
                                            &#1502;&#1514;&#1495;&#1497;&#1500;&#1514; &#1489;&#1497;&#1510;&#1493;&#1506; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;
                                            &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1504;&#1506;&#1512;&#1498; &#1492;&#1505;&#1499;&#1501;
                                            &#1489;&#1499;&#1514;&#1489; &#1489;&#1497;&#1503; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491;
                                            &#1500;&#1489;&#1497;&#1503; &#1492;&#1506;&#1493;&#1489;&#1491; &#1493;&#1489;&#1493;:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#1488;)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1492;&#1505;&#1499;&#1502;&#1514;
                                            &#1492;&#1506;&#1493;&#1489;&#1491; &#1500;&#1492;&#1505;&#1491;&#1512; &#1500;&#1508;&#1497;
                                            &#1488;&#1497;&#1513;&#1493;&#1512; &#1494;&#1492; &#1489;&#1504;&#1493;&#1505;&#1495; &#1492;&#1502;&#1508;&#1512;&#1496;
                                            &#1488;&#1514; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491;
                                            &#1493;&#1488;&#1514; &#1511;&#1512;&#1503; &#1492;&#1508;&#1504;&#1505;&#1497;&#1492; &#1493;&#1511;&#1493;&#1508;&#1514;
                                            &#1492;&#1489;&#1497;&#1496;&#1493;&#1495;, &#1500;&#1508;&#1497; &#1492;&#1506;&#1504;&#1497;&#1503;;
                                            &#1489;&#1492;&#1505;&#1499;&#1501; &#1492;&#1488;&#1502;&#1493;&#1512; &#1497;&#1497;&#1499;&#1500;&#1500;
                                            &#1490;&#1501; &#1504;&#1493;&#1505;&#1495;&#1493; &#1513;&#1500; &#1488;&#1497;&#1513;&#1493;&#1512;
                                            &#1494;&#1492;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#1489;)
<SUP>[4]</SUP>&#9;&#1493;&#1497;&#1514;&#1493;&#1512; &#1492;&#1502;&#1506;&#1489;&#1497;&#1491; &#1502;&#1512;&#1488;&#1513; &#1506;&#1500;
&#1499;&#1500; &#1494;&#1499;&#1493;&#1514; &#1513;&#1497;&#1499;&#1493;&#1500;&#1492; &#1500;&#1492;&#1497;&#1493;&#1514; &#1500;&#1493;
&#1500;&#1492;&#1495;&#1494;&#1512; &#1499;&#1505;&#1508;&#1497;&#1501; &#1502;&#1514;&#1493;&#1498; &#1514;&#1513;&#1500;&#1493;&#1502;&#1497;&#1493;,
&#1488;&#1500;&#1488; &#1488;&#1501; &#1499;&#1503; &#1504;&#1513;&#1500;&#1500;&#1492; &#1494;&#1499;&#1493;&#1514; &#1492;&#1506;&#1493;&#1489;&#1491;
&#1500;&#1508;&#1497;&#1510;&#1493;&#1497;&#1497; &#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501; &#1489;&#1508;&#1505;&#1511; &#1491;&#1497;&#1503;
&#1502;&#1499;&#1495; &#1505;&#1506;&#1497;&#1508;&#1497;&#1501; 16 &#1488;&#1493; 17 &#1500;&#1495;&#1493;&#1511; &#1493;&#1489;&#1502;&#1497;&#1491;&#1492;
&#1513;&#1504;&#1513;&#1500;&#1500;&#1492; &#1488;&#1493; &#1513;&#1492;&#1506;&#1493;&#1489;&#1491; &#1502;&#1513;&#1498; &#1499;&#1505;&#1508;&#1497;&#1501;
&#1502;&#1511;&#1512;&#1503; &#1492;&#1508;&#1504;&#1505;&#1497;&#1492; &#1488;&#1493; &#1502;&#1511;&#1493;&#1508;&#1514; &#1492;&#1489;&#1497;&#1496;&#1493;&#1495;
&#1513;&#1500;&#1488; &#1489;&#1513;&#1500; &#1488;&#1497;&#1512;&#1493;&#1506; &#1502;&#1494;&#1499;&#1492;; &#1500;&#1506;&#1504;&#1497;&#1503;
&#1494;&#1492;, &ldquo;&#1488;&#1497;&#1512;&#1493;&#1506; &#1502;&#1494;&#1499;&#1492;&rdquo; - &#1502;&#1493;&#1514;, &#1504;&#1499;&#1493;&#1514;
&#1488;&#1493; &#1508;&#1512;&#1497;&#1513;&#1492; &#1489;&#1490;&#1497;&#1500; &#1513;&#1513;&#1497;&#1501; &#1488;&#1493; &#1497;&#1493;&#1514;&#1512;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(&#1490;)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1488;&#1497;&#1503;
                                            &#1489;&#1488;&#1497;&#1513;&#1493;&#1512; &#1494;&#1492; &#1499;&#1491;&#1497; &#1500;&#1490;&#1512;&#1493;&#1506;
                                            &#1502;&#1494;&#1499;&#1493;&#1514;&#1493; &#1513;&#1500; &#1506;&#1493;&#1489;&#1491; &#1500;&#1508;&#1497;&#1510;&#1493;&#1497;&#1497;
                                            &#1508;&#1497;&#1496;&#1493;&#1512;&#1497;&#1501; &#1500;&#1508;&#1497; &#1492;&#1495;&#1493;&#1511;,
                                            &#1492;&#1505;&#1499;&#1501; &#1511;&#1497;&#1489;&#1493;&#1510;&#1497;, &#1510;&#1493; &#1492;&#1512;&#1495;&#1489;&#1492;
                                            &#1488;&#1493; &#1495;&#1493;&#1494;&#1492; &#1506;&#1489;&#1493;&#1491;&#1492;, &#1489;&#1490;&#1497;&#1503;
                                            &#1513;&#1499;&#1512; &#1513;&#1502;&#1506;&#1489;&#1512; &#1500;&#1513;&#1499;&#1512; &#1492;&#1502;&#1493;&#1508;&#1496;&#1512;.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.3pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: center; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1488;&#1500;&#1497;&#1492;&#1493;
&#1497;&#1513;&#1497;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: center; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1513;&#1512;
&#1492;&#1506;&#1489;&#1493;&#1491;&#1492; &#1493;&#1492;&#1512;&#1493;&#1493;&#1495;&#1492;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 28.3pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#1492;&#1506;&#1493;&#1489;&#1491;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#1492;&#1495;&#1489;&#1512;&#1492;</FONT></TD></TR>
</TABLE>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[1]
                                            </SUP>&#1497;&quot;&#1508; 4659 (30.6.98), &#1506;&#1502;' 4394; &#1514;&#1497;&#1511;&#1493;&#1504;&#1497;&#1501;:
                                            &#1497;&quot;&#1508; 4803, &#1492;&#1514;&#1513;&quot;&#1505; (19.9.99), &#1506;&#1502;'
                                            5; &#1497;&quot;&#1508; 4970, &#1492;&#1514;&#1513;&#1505;&quot;&#1488; (12.3.01), &#1506;&#1502;'
                                            1949</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[2]
</SUP>&#1505;&quot;&#1495; &#1492;&#1514;&#1513;&#1499;&quot;&#1490;, &#1506;&#1502;' 136</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[3]
</SUP>&#1511;&quot;&#1514; &#1492;&#1514;&#1513;&#1499;&quot;&#1491;, &#1506;&#1502;' 1302</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[4]
</SUP>&#1514;&#1497;&#1511;&#1493;&#1503;: &#1497;&quot;&#1508; 4803, &#1492;&#1514;&#1513;&quot;&#1505; (23.8.99)</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;<IMG SRC="ex10-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ANNEX
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>to
the Agreement between Rachel Vaknin and Microbot Medical Ltd. (the &ldquo;Company&rdquo;), dated</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>November___,
2021</U></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFIDENTIALITY,
NON-COMPETITION, NON-SOLICITATION, INTELLECTUAL PROPERTY ASSIGNMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annex B is entered into by the Company and I, Rachel Vaknin, the undersigned, as part of my employment agreement with the Company to
which this Annex B is attached (the &ldquo;<B>Agreement</B>&rdquo;). Any capitalized term not defined in this Annex B shall have the
meaning ascribed to such term in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to my undertaking under Section 4.3 of the Agreement, I hereby acknowledge, confirm and undertake to the Company as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Confidentiality</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            acknowledge that in the framework and/or as a result of my employment with the Company I
                                            may (or may have) receive(d), learn(ed), be(en) expos(ed) to, obtain(ed), or have (or had)
                                            access to non-public proprietary and other confidential information relating to the Company,
                                            its business and activities, including without limitation any commercial, financial, business,
                                            professional, technical, technological information, including information regarding the Company&rsquo;s
                                            (actual or planned) products, services, inventions, discoveries, studies, techniques, research
                                            and developments, processes, specifications, data, know-how, improvements, trade secrets,
                                            computer programs, software (in source and object code), databases and any intellectual property,
                                            information regarding marketing, operations, plans, activities, policies and procedures,
                                            employees, customers, suppliers, business partners, etc., including information of third
                                            parties (with respect to which the Company may have a duty of confidentiality), all whether
                                            or not marked confidential and whether disclosed in written, oral or other format (collectively,
                                            the &ldquo;<B>Confidential Information</B>&rdquo;), which is highly confidential and of great
                                            value to the Company and which may constitute professional and/or commercial secrets. For
                                            the sake of clarity, Confidential Information shall be deemed to include all notes, summaries,
                                            analyses, studies or other documents prepared by me or any other person which contain, or
                                            are based upon, in whole or in part, any Confidential Information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            confirm and agree that, all right, title and interest in and to all Confidential Information
                                            is and shall remain the sole and exclusive property of the Company or the third party providing
                                            such Confidential Information to the Company, as the case may be.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
                                            my period of employment with the Company and thereafter (without any fixed limitation of
                                            time), I undertake to maintain all Confidential Information in strict confidence at all times
                                            and not to, directly or indirectly, whether in writing, orally or otherwise, communicate,
                                            publish, reveal, describe, divulge or otherwise disclose or make available any of the Confidential
                                            Information or allow its exposure or disclosure, in whole or in part, to any individual or
                                            entity, and not to use any of the Confidential Information for any purpose other than for
                                            the performance of my duties and obligations on behalf of the Company under the Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 1.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the Confidential Information shall not include information that I prove using documented evidence to be (a) generally
available to the public not as a result of any fault of mine or any person acting on my behalf; or (b) furnished to me prior to my association
with the Company, without any obligation of confidentiality and/or use restrictions by a third party without breaching a confidential
obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 1.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 1.35pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 1.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the event that I will be required to disclose pursuant to an order of a court of competent
                                            jurisdiction or by applicable law or regulation any Confidential Information, I undertake
                                            that: (i) such disclosure will be made only to the extent and solely to the recipient legally
                                            required; and (ii) the Company will be provided by me with sufficient prior written notice
                                            of such legal requirement so as to have the opportunity to oppose the disclosure or obtain
                                            a protective order.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            have not and will not improperly or wrongfully use(d) or disclose(d) any non-public proprietary
                                            information, documentation, trade secrets or other confidential information of any former
                                            employer or any previously approved concurrent employer or other person and I will not bring
                                            onto the premises of the Company or otherwise use on behalf of or to the benefit of the Company
                                            any such information belonging to any such employer, person or third party unless consented
                                            to in writing by such employer, person or third party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            the earlier of the Company&rsquo;s request or upon the termination of this Agreement, I shall
                                            return to the Company any and all documents and other tangible materials containing Confidential
                                            Information and shall erase or destroy any computer or data files containing such Confidential
                                            Information, such that no copies or samples of Confidential Information shall remain with
                                            me. I agree that the Company has the right to inspect my property to reasonably ensure that
                                            no such materials remain in my possession.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Intellectual
                                            Property Rights</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            derogating from the Company&rsquo;s rights under any law and/or agreement, I confirm and
                                            agree that any and all discoveries, ideas, developments, inventions research , formulae,
                                            improvements, works of authorship, mask works, trade secrets, modifications, concepts, techniques,
                                            specifications, computer software or programs (in source and in object code), data bases,
                                            products (actual or planned), methods, technologies, know-how, designs, trademark data, processes
                                            and proprietary information, &ldquo;Service Inventions&rdquo; under Section 132 of the Patent
                                            Law-1967, whether or not patentable, copyrightable or otherwise protectable, (collectively,
                                            &ldquo;<B>Inventions</B>&rdquo;), which were or shall be made, invented, developed, discovered,
                                            conceived, or created by me, in whole or in part, independently or jointly with others: (i)
                                            prior to my employment with the Company for the benefit of and/or on behalf of the Company;
                                            and/or (ii) as a result of and/or during the period of my employment with the Company; and/or
                                            (iii) with the use of any equipment, supplies, facilities, property or proprietary information
                                            belonging to the Company, or any intellectual property rights therein, related thereto or
                                            associated therewith such as (but not limited to) copyrights and copyrights applications,
                                            patents and patent applications (collectively, &ldquo;<B>IP Rights</B>&rdquo;), (such Inventions
                                            and IP Rights, shall be referred to herein as &ldquo;<B>Company IP</B>&rdquo;) are and shall
                                            be the sole and exclusive property of the Company, and I shall have no rights, claims or
                                            interest whatsoever in or with respect thereto, and for the removal of doubt, I hereby irrevocably
                                            and unconditionally assign (and agree to assign in the future upon the vesting of any such
                                            rights in me) to the Company any and all rights title and interest, in and to any and all
                                            Company IP.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without
                                            derogating from the generality of the foregoing, I hereby irrevocably confirm that, the Salary
                                            to which I am entitled under the Agreement includes and incorporates full and appropriate
                                            compensation for any and all right I may have to any Company IP which are assigned to the
                                            Company, and I shall not be entitled to any additional compensation whatsoever with respect
                                            to any Company IP or for fulfilling my duties hereunder, and I hereby irrevocably waive any
                                            claim and/or demand to any right, moral rights, compensation or reward, including any right
                                            for any royalties or other compensation in Inventions based on Section 134 of Israeli Patent
                                            Law-1967.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot Medical
LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            further agree and undertake that if and to the extent any additional action is required from
                                            me in order to perfect, enforce, or defend said Company IP, and effectuate or confirm the
                                            Company&rsquo;s title and interest therein, including to effect the formal transfer thereof
                                            to the Company, I shall take all necessary measures and fully cooperate, during and after
                                            the term of my employment, and perform any such action promptly upon the Company&rsquo;s
                                            request. Additionally, I undertake to promptly disclose to the Company and transfer thereto
                                            any and all information and details with respect to the Company IP, to keep accurate records
                                            relating to the conception and reduction to practice of all Company IP (which records shall
                                            be the sole and exclusive property of the Company and shall be surrendered to the possession
                                            of the Company, immediately upon their creation), and to provide the Company with all information,
                                            documentation, and assistance, including the preparation or execution, as applicable, of
                                            documents, declarations, assignments, drawings and other data. It is hereby agreed that in
                                            case I will be required to assist the Company as described above after the termination of
                                            my employment with the Company, for any reason, the Company shall reimburse me for any reasonable
                                            expenses, including reasonable loss of time expenses, in connection therewith.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Company (or any of its assigns) is unable because of my mental or physical incapacity
                                            or for any other reason to secure my signature to or to apply for or to pursue any application
                                            for any domestic or foreign patents or copyright registrations covering any of the Company
                                            IP, or to further any of the purposes as described above, then I hereby irrevocably designate
                                            and appoint the Company and its duly authorized officers, agents and assigns as my agent
                                            and attorney in fact, to act for and in my behalf and stead to execute and file any such
                                            applications and to do all other lawfully permitted acts to further the above purposes, including
                                            without limitation the prosecution and issuance of letters patent or copyright registrations
                                            thereon, with the same legal force and effect as if executed by me.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Non
                                            Competition and Non-Solicitation</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            undertake that, without the express prior written consent of the Company (such consent to
                                            be given or withheld in the sole discretion of the Company) as long as I am employed by the
                                            Company and for a period of twelve (12) months thereafter: (a) I shall not, directly or indirectly,
                                            be involved in any activity which is competitive with the Company or any of its businesses,
                                            including without limitation in the field of medical device (b) I shall not, directly or
                                            indirectly, engage in any activity with or for the benefit of any individual or entity, which
                                            at the time of the termination of my employment with the Company, or during the period of
                                            twelve (12) months prior thereto, was in contact of the Company, including without limitation
                                            any of the Company&rsquo;s customers, suppliers, consultants, advisors, service providers,
                                            employees, and the like, or any active prospect of any of the foregoing persons (each, a
                                            &ldquo;<B>Third Party</B>&rdquo;) with respect to business activity of the kind and/or in
                                            the field that the Company engages in or discussed engaging in with such Third Party and/or
                                            take any action which could interfere with the relationship of the Company with such Third
                                            Party; and (c) I shall not, directly or indirectly, employ, offer to employ or otherwise
                                            solicit for employment or engagement any person who is or was, during the 12 (twelve) month
                                            period prior to the termination of my employment with the Company, an employee or consultant,
                                            supplier or contractor of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of this Section 3 of this Annex B, &ldquo;directly or indirectly&rdquo; includes engaging in business as an owner, an independent
contractor, shareholder, director, partner, manager, agent, employee or advisor. However, such a reference does not include the holding
of shares of a publicly traded company which constitute no more than 5% of the issued share capital of such traded company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex10-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            confirm that the compensation in the Agreement, with respect to which negotiations were conducted,
                                            includes and incorporates special non-compete compensation as set forth in <U>Annex A</U>,
                                            which constitutes full and appropriate compensation for my undertaking not to compete in
                                            Section 3.1 of this Annex B above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>General</U></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            the purpose of this Annex B, the term &ldquo;Company&rdquo; shall include any parent, subsidiary
                                            and/or affiliated entities of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">My
                                            undertakings stipulated in this Annex B shall survive the termination of the Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the event of termination of my employment with the Company, I hereby grant my consent to
                                            the Company to (a) notify my new employer about my rights and obligations hereunder, and
                                            (b) give the Company permission to send my new employer a copy of this Annex B.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            provisions of this Annex B are in addition to, and not in lieu of, any statutory or other
                                            contractual or legal obligation that the Company may have relating to the subject matter
                                            addressed herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            the event that any of my undertakings in this Annex B are adjudicated to be invalid or unenforceable,
                                            such provision will be enforced to the maximum extent allowed by law given the intent of
                                            the Company and myself as expressed in this Annex B. The unenforceability of any term (or
                                            part thereof) shall not affect the enforceability of any other part of these undertakings
                                            made by me hereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            am aware that the breach or threatened breach of this Annex B or any part thereof may cause
                                            the Company and/ or its customers, severe and irreversible damage, to which monetary damages
                                            would not constitute sufficient remedy. Without derogating from any other remedies to which
                                            the Company may be entitled, including without limitation, pursuant to the Israeli Commercial
                                            Wrongs Law-1999, I agree that the Company will be entitled to injunctive relief to enforce
                                            my undertakings (or any breach thereof) under this Annex B.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0%"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
                                            represent that my performance of the terms of this Annex B and my duties as an employee of
                                            the Company do not and will not breach any agreement I have with, or any other obligation
                                            I owe to, any former employer or other party.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have read all that which is stated above and I hereby undertake to comply with all that which is written, and in witness whereof, I hereby
affix my signature to this Annex B, on this ___ day of the month of November 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
Name: Rachel Vaknin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:
<U>/s/ Rachel Vaknin</U>_________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Microbot
                                            Medical LTD. 6 HaYozma St, Yokneam, 2069204. Israel, P.B 242,</FONT></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel: 972-4-8200710,
Fax: 972-4-8200712 <U>www.microbotmedical.com</U></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>









<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_01.jpg
<TEXT>
begin 644 ex99-1_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !7 .$# 2(  A$! Q$!_\0
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M$D$$#M715Y)X#_Y'"/\ Z]W_ )BO6Z "BBB@ HHHH ***S-6UVRT8QBZ9@9
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex10-1_001.jpg
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! *4# 2(  A$! Q$!_\0
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M3B\<WLDEBO\ 83D7T9:V"SC+L/PX'UJ5?'*IX?>_GLBERET;4P>9QOZ_>QP
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8B@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mbot-20220401.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamGGbP9z5Z8qekhvWBzbXmafyAhmE6MDC5yKgn2cU4G -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:MBOT="http://microbotmedical.com/20220401" elementFormDefault="qualified" targetNamespace="http://microbotmedical.com/20220401">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://microbotmedical.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="mbot-20220401_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="mbot-20220401_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>mbot-20220401_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>mbot-20220401_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://microbotmedical.com/role/Cover" xlink:href="mbot-20220401.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://microbotmedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140601334569128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MICROBOT
MEDICAL INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3078125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">25
    Recreation Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Unit 108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hingham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">875-3605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBOT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbot-20220401.xsd" xlink:type="simple"/>
    <context id="From2022-04-01to2022-04-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883975</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-04-01to2022-04-01">0000883975</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-04-01to2022-04-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-04-01to2022-04-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-04-01to2022-04-01">2022-04-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-04-01to2022-04-01">MICROBOT MEDICAL INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-04-01to2022-04-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-04-01to2022-04-01">000-19871</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-04-01to2022-04-01">94-3078125</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-04-01to2022-04-01">25     Recreation Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-04-01to2022-04-01">Unit 108</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-04-01to2022-04-01">Hingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-04-01to2022-04-01">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-04-01to2022-04-01">02043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-04-01to2022-04-01">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-04-01to2022-04-01">875-3605</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-04-01to2022-04-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-04-01to2022-04-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-04-01to2022-04-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-04-01to2022-04-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-04-01to2022-04-01">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-04-01to2022-04-01">MBOT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-04-01to2022-04-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-04-01to2022-04-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MPQF\!/8"^'ZEE'D?V(UP\3M&_Q]02P,$%     @ L8"&5)^@&_"Q @  X@P
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MB^$_7G\!4$L! A0#%     @ L8"&5 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "Q@(94$.*\5^X
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +& AE27BKL<P    !,"   +
M      "  6L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( +& AE2JQ"(6,P$
M "("   /              "  500  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " "Q@(94)!Z;HJT   #X 0  &@              @ &T$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "Q@(9499!YDAD!  #/
M P  $P              @ &9$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  #C$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://microbotmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex99-1.htm</File>
    <File>mbot-20220401.xsd</File>
    <File>mbot-20220401_lab.xml</File>
    <File>mbot-20220401_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mbot-20220401_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbot-20220401_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mbot-20220401.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "MBOT",
   "nsuri": "http://microbotmedical.com/20220401",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-04-01to2022-04-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://microbotmedical.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-04-01to2022-04-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-22-009272-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-009272-xbrl.zip
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M'1XIMR!YX%@083PDQ/ 5@9) /8 /<PPA2/T%A-#'BR_!2>?X^'C-0C\I)@;
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MQ';X_=N$I91X_UX X7F2>H(B=04/9T@@2)N85M?=$4]3U6PM"^HH-GH"$>4
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M%=F01Q&+>5(LKOO1WC=[K^O?_<DX:WX9!N]2>Z#-LXDJ1557\T UJN??516
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MA:7&!#-5$\L7EU%3G4JF "!]*9_HKI,X^3 I!JINX)(B8&R07/GC,N3!O#(
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MR<!&E>6H#"X-A%_!+UZ]?7UR1@6D$[I))EP?"6F#C*G /8]M35^63J1:V$F
M73D9ADV)JV%Y)TQW Z(NG.JID@S)[U22&1=&=^&TCQP>L<UH\ WCV%O)Z"T2
M_H<ND(Y-4-#.8D4^3E)9:CQ134Z(@^'##NT/,%**;5"8Y+^_BB1GU/[)8:$
MH4# "L@QV.R!N)R:1@$7FH1EF00MRDXCDAC5X$2ST5S;IY8QMLX8QHU2)WI
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MDQE&@>_QT0C-# )!YD &G0_XMV6"ADW%, %E?X0I!D#5IJ*PXX@EEPCA:9J
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ML/[ D#OB0^+(IRPU%CO_SH>%^EUFY5-UO"NV&"PF1C>Q7)X.ITL?C?XH9==
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M 2G$#-ZF+*M5:KBT$#1@9R KA.O6S[31G:WMUV%/Q 7@K93-.:P Q1L*,KJ
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M9HR(>H+WN8K IQX)3;L:2MW9=30!0HB J0LNHG,(2!+JW%X2$M* @F\A1<0
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M6-F!F+^"#S1'^4_%MHF\WQHM.]/4RS]02P,$%     @ L8"&5-^\/<?_"@
M;(<  !4   !M8F]T+3(P,C(P-# Q7VQA8BYX;6S-G5]3Z[@9QN\[T^^@IC?M
MS DY"6UG8 ^[P\F!G<RR0$G.V;8[G1W%%L&#(U'9@?#M*]F68TMZ;4.GDKB
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MVV?=EO\!4$L! A0#%     @ L8"&5 1:02T76P  ?GT#  H
M ( !     &5X,3 M,2YH=&U02P$"% ,4    " "Q@(94FO@0NA\,  #K,@
M"@              @ $_6P  97@Y.2TQ+FAT;5!+ 0(4 Q0    ( +& AE3<
M<!NX5AD  $#.   +              "  89G  !F;W)M."UK+FAT;5!+ 0(4
M Q0    ( +& AE0L0[)/0 ,   H,   1              "  06!  !M8F]T
M+3(P,C(P-# Q+GAS9%!+ 0(4 Q0    ( +& AE3?O#W'_PH  &R'   5
M          "  72$  !M8F]T+3(P,C(P-# Q7VQA8BYX;6Q02P$"% ,4
M" "Q@(940J$M'ED'  #/6   %0              @ &FCP  ;6)O="TR,#(R
B,#0P,5]P<F4N>&UL4$L%!@     &  8 ;@$  #*7      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
